4.20
-0.01(-0.24%)
Currency In USD
| Previous Close | 4.21 |
| Open | 4.23 |
| Day High | 4.45 |
| Day Low | 4.08 |
| 52-Week High | 5.89 |
| 52-Week Low | 1.99 |
| Volume | 26,715 |
| Average Volume | 134,514 |
| Market Cap | 158.65M |
| PE | -4.94 |
| EPS | -0.85 |
| Moving Average 50 Days | 3.61 |
| Moving Average 200 Days | 3.23 |
| Change | -0.01 |
If you invested $1000 in Genelux Corporation (GNLX) since IPO date, it would be worth $682.93 as of September 29, 2025 at a share price of $4.2. Whereas If you bought $1000 worth of Genelux Corporation (GNLX) shares 1 year ago, it would be worth $1,772.15 as of September 29, 2025 at a share price of $4.2.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference
GlobeNewswire Inc.
Sep 02, 2025 8:01 PM GMT
WESTLAKE VILLAGE, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board and Matt Pulisic, Chief F
Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development
GlobeNewswire Inc.
Jul 07, 2025 11:00 AM GMT
WESTLAKE VILLAGE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced the appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance
Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference
GlobeNewswire Inc.
May 01, 2025 8:05 PM GMT
WESTLAKE VILLAGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board, and Matt Pulisic, CFO, wil